These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 813917)

  • 1. Prolactin concentrations in patients with acromegaly: clinical significance and response to surgery.
    Franks S; Jacobs HS; Nabarro JD
    Clin Endocrinol (Oxf); 1976 Jan; 5(1):63-9. PubMed ID: 813917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly.
    Arafah BM; Rosenzweig JL; Fenstermaker R; Salazar R; McBride CE; Selman W
    J Lab Clin Med; 1987 Mar; 109(3):346-54. PubMed ID: 3102658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.
    Abbassioun K; Amirjamshidi M; Mehrazin A; Khalatbary I; Keynama M; Bokai H; Abdollahi M
    Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuated pulse size, disorderly growth hormone and prolactin secretion with preserved nyctohemeral rhythm distinguish irradiated from surgically treated acromegaly patients.
    van der Klaauw AA; Pereira AM; van Thiel SW; Frolich M; Iranmanesh A; Veldhuis JD; Roelfsema F; Romijn JA
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):489-98. PubMed ID: 17371464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of acromegaly by transsphenoidal surgery.
    Tucker HS; Grubb SR; Wigand JP; Watlington CO; Blackard WG; Becker DP
    Arch Intern Med; 1980 Jun; 140(6):795-802. PubMed ID: 7387274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
    Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
    Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
    J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatomedin A increments are diminished in acromegaly with concomitant hyperprolactinaemia.
    Hulting AL; Hall K; Werner S
    Acta Endocrinol (Copenh); 1984 Jul; 106(3):305-10. PubMed ID: 6429988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings: Prolactin concentrations in patients with acromegaly: relation to growth hormone levels before and after surgery.
    Franks S; Jacobs HS; Nabarro JD
    J Endocrinol; 1975 Jun; 65(3):25P-26P. PubMed ID: 1151225
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
    Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine levels in acromegaly patients.
    Hekimsoy Z; Ozmen B; Ulusoy S
    Neuro Endocrinol Lett; 2005 Dec; 26(6):811-4. PubMed ID: 16380700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum growth hormone and prolactin response to thyrotropin-releasing hormone in patients with acromegaly before and after surgery.
    Samaan NA; Leavens ME; Jesse RH
    J Clin Endocrinol Metab; 1974 Jun; 38(6):957-63. PubMed ID: 4208807
    [No Abstract]   [Full Text] [Related]  

  • 14. Bromocriptine therapy in patients with acromegaly: effects on growth hormone, somatomedin A and prolactin.
    Werner S; Hall K; Sjöberg HE
    Acta Endocrinol Suppl (Copenh); 1978; 216():199-206. PubMed ID: 347862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transsphenoidal microsurgery in the treatment of acromegaly and gigantism.
    Arafah BU; Brodkey JS; Kaufman B; Velasco M; Manni A; Pearson OH
    J Clin Endocrinol Metab; 1980 Mar; 50(3):578-85. PubMed ID: 6244327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin secretion in patients with chromophobe adenomas of the pituitary: incidence and presentation of hyperprolactinaemia: results of surgical treatment.
    Franks S; Nabarro JD
    Ann Clin Res; 1978; 10(3):157-63. PubMed ID: 718118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma growth hormone profile in acromegaly before and ten days after transsphenoidal surgery.
    Edén S; Bengtsson BA; Albertsson-Wikland K; Elfversson J; Lindstedt G; Lundberg PA; Petruson B; Rosberg S
    Acta Endocrinol (Copenh); 1989 Jan; 120(1):113-20. PubMed ID: 2492135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma growth hormone responses to sulpiride in patients with acromegaly.
    Hanew K; Sato S; Sasaki A; Kasai M; Shimizu Y; Murakami O; Yoshinaga K
    Tohoku J Exp Med; 1984 Apr; 142(4):445-52. PubMed ID: 6429896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of plasma prolactin levels in the prediction of the responsiveness of growth hormone secretion to bromocriptine and TRH in acromegaly.
    Lamberts SW; Liuzzi A; Chiodini PG; Verde S; Klijn JG; Birkenhäger JC
    Eur J Clin Invest; 1982 Apr; 12(2):151-5. PubMed ID: 6807686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acromegaly associated with a bronchial carcinoid tumor: evidence for ectopic production of growth hormone-releasing activity.
    Saeed uz Zafar M; Mellinger RC; Fine G; Szabo M; Frohman LA
    J Clin Endocrinol Metab; 1979 Jan; 48(1):66-71. PubMed ID: 422708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.